Avacta Group (AVCT)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

44.88p
   
  • Change Today:
    -1.62p
  • 52 Week High: 159.60
  • 52 Week Low: 44.50
  • Currency: UK Pounds
  • Shares Issued: 359.04m
  • Volume: 2,044,893
  • Market Cap: £161.14m
  • RiskGrade: 461
  • Beta: 0.06

Deal with Barclays    Trade now with Barclays Stockbrokers

Avacta still waiting on MHRA approval for Covid-19 test

By Josh White

Date: Friday 28 May 2021

LONDON (ShareCast) - (Sharecast News) - Cancer therapies and diagnostics developer Avacta Group responded to speculation around the CE-mark submission for its SARS-CoV-2 antigen lateral flow test on Friday.
The AIM-traded firm said the submission had been made to the Medicines and Healthcare products Regulatory Agency (MHRA) by its partner Mologic.

"To date, neither Avacta nor Mologic have received any update from the MHRA," the board said in its statement.

"Avacta will update the market when it is in a position to do so."

At 0829 BST, shares in Avacta Group were up 0.81% at 245.97p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Avacta Group Market Data

Currency UK Pounds
Share Price 44.88p
Change Today -1.62p
% Change -3.48 %
52 Week High 159.60
52 Week Low 44.50
Volume 2,044,893
Shares Issued 359.04m
Market Cap £161.14m
Beta 0.06
RiskGrade 461

Avacta Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
34.39% below the market average34.39% below the market average34.39% below the market average34.39% below the market average34.39% below the market average
56.86% below the sector average56.86% below the sector average56.86% below the sector average56.86% below the sector average56.86% below the sector average
Price Trend
85.71% below the market average85.71% below the market average85.71% below the market average85.71% below the market average85.71% below the market average
52.73% below the sector average52.73% below the sector average52.73% below the sector average52.73% below the sector average52.73% below the sector average
Income Not Available
Growth
62.05% above the market average62.05% above the market average62.05% above the market average62.05% above the market average62.05% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average

What The Brokers Say

Strong Buy 0
Buy 2
Neutral 0
Sell 1
Strong Sell 0
Total 3
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Avacta Group Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
13:43 70,000 @ 45.00p
13:40 25,000 @ 45.00p
13:40 25,000 @ 45.00p
13:39 70,000 @ 45.02p
13:35 50,000 @ 45.00p

Avacta Group Key Personnel

CFO Tony Peter Gardiner
CEO Christina Coughlin

Top of Page